Skip to main content
Sensei Biotherapeutics, Inc. logo

Sensei Biotherapeutics, Inc. — Investor Relations & Filings

Ticker · SNSE ISIN · US81728A1088 LEI · 8945002MP2CXKAENWU30 US Manufacturing
Filings indexed 382 across all filing types
Latest filing 2026-05-22 Proxy Solicitation & In…
Country US United States of America
Listing US SNSE

About Sensei Biotherapeutics, Inc.

https://www.senseibio.com/

Sensei Biotherapeutics, Inc. is a clinical-stage immuno-oncology company that discovers and develops next-generation therapeutics for cancer patients. The company's approach focuses on the tumor microenvironment (TME), developing conditionally active antibodies designed to function selectively within it. This strategy aims to create highly selective treatments against challenging immuno-oncology targets by leveraging the immune system's natural capabilities to combat cancer.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement
2026-05-22 English
8-K
Regulatory Filings
2026-05-22 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-21 English
8-K
Regulatory Filings
2026-05-21 English
S-8
Regulatory Filings
2026-05-15 English
10-Q
Interim / Quarterly Report
2026-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.